Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Aclaris Therapeutics, Inc. (ACRS) had Income from Continuous Operations of $-16.94M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$2.40M |
|
$-16.94M |
|
$1.84M |
|
$0.56M |
|
$21.33M |
|
$-18.93M |
|
$1.99M |
|
$-16.94M |
|
$-16.94M |
|
$-16.94M |
|
|
Income from Continuous Operations |
$-16.94M |
$-16.94M |
|
$-16.94M |
|
$-18.93M |
|
$-18.69M |
|
71.07M |
|
71.07M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$135.34M |
|
$1.53M |
|
$38.73M |
|
$174.06M |
|
$20.08M |
|
-- |
|
$11.97M |
|
$32.05M |
|
$142.01M |
|
$142.01M |
|
$142.01M |
|
71.25M |
|
| Cash Flow Statement Financials | |
$-20.82M |
|
$16.83M |
|
$-0.06M |
|
$39.88M |
|
$35.84M |
|
$-4.04M |
|
$2.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
23.27% |
|
-789.45% |
|
-789.45% |
|
-- |
|
-706.46% |
|
-706.46% |
|
$-20.95M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
6.43 |
|
14.00 |
|
-11.93% |
|
-11.93% |
|
-9.73% |
|
-11.93% |
|
$1.99 |
|
$-0.29 |
|
$-0.29 |
|